Geographic location is a prominent factor in treatment accessibility, particularly for clients living or seeking treatment in Remote & very remote areas of Australia (AIHW 2019).
While the greatest numbers of treatment episodes for alcohol and amphetamines were provided in Major cities, accounting for population differences, the remoteness area with the highest rate differed based on principal drug of concern:
- Alcohol: in 2020–21, 953 episodes per 100,000 people were delivered to clients living in Remote & very remote areas, more than 4 times greater than the 229 episodes per 100,000 people delivered to clients in Major cities. The rate of episodes per 100,000 people increased with increasing remoteness, a trend consistently observed from 2014–15 to 2020–21.
-
Between 2013–14 and 2020–21, the proportion of end reasons of episodes treating alcohol remained relatively consistent across most remoteness areas. The exception was Remote & very remote areas, which saw a sharp increase in numbers of information and education episodes in 2018–19 (1,240 episodes, or a 10-fold increase from the previous year) and 2019–20 (2,028 episodes). The majority of this increase was episodes that ended as planned (89% and 97% respectively).
- Amphetamines: in 2020–21, clients living in Inner regional areas had the highest rate of episodes (220 episodes per 100,000 people), with the rate of episodes then decreasing with increasing remoteness. This trend is observed in most years from 2013–14 to 2020–21.
For further detail, refer to Supplementary tables BLTN.16 and BLTN.17.